0 results available. Select is focused ,type to refine list, press Down to open the menu,
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the...
The following section summarizes insights on Roche Holding AG Participation's Capital Expenditures Forecast (FINBOX):
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Capital Expenditures Forecast (FINBOX) in the forecast category include:
Projected capital expenditures.
The chart above depicts the distribution of capital expenditures forecast (finbox) for companies operating in the Healthcare sector in the Developed economic region. Over 2,560 companies were considered in this analysis, and 2,511 had meaningful values. The average capital expenditures forecast (finbox) of companies in the sector is 20.041 M with a standard deviation of 70.197 M.
Roche Holding AG Participation's Capital Expenditures Forecast (FINBOX) of 3.953 B is significantly outside the interquartile range and is excluded from the distribution. The following table provides additional summary stats:
Economic Risk Region | Developed |
Total Constituents | 2,562 |
Included Constituents | 2,511 |
Min | 0 K |
Max | 629.6 M |
Median | 771.046 K |
Mean | 20.041 M |
Standard Deviation | 70.197 M |
You can find companies with similar capital expenditures forecast (finbox) using this stock screener.